Cornell, R. F., Baz, R., Richter, J. R., Rossi, A., Vogl, D. T., Chen, C., Shustik, C., Alvarez, M. J., Shen, Y., Unger, T. J., Ben‐Shahar, O., Wang, H., Baloglu, E., Senapedis, W., Ma, X., Landesman, Y., Bai, X., Bader, J., Xu, H., Marshall, T., Chang, H., Walker, C. J., Shah, J., Shacham, S., Kauffman, M. G., & Hofmeister, C. C. (2022). a phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma. American journal of hematology, 97(2), E54–E58. http://access.bl.uk/ark:/81055/vdc_100148622874.0x000046